Bill > SB927

This bill regulates the sale of kratom, a plant-derived product, by establishing comprehensive restrictions and labeling requirements. It defines kratom products as substances derived from the Mitragyna speciosa plant and prohibits their sale under specific conditions, such as to individuals under 21 years old, in adulterated forms, or in child-appealing packaging. The bill mandates that kratom products must have detailed labels including manufacturer information, full ingredient list, health warnings about potential habit-forming properties and medication interactions, and precise serving recommendations. Retailers are required to verify age through government-issued photo identification and are forbidden from displaying kratom products where they can be accessed by minors. The legislation also restricts kratom products containing more than two percent 7-hydroxymitragynine in their alkaloid composition and prohibits products with synthesized or semi-synthesized alkaloids. Violations of these provisions are considered unlawful practices, and the bill allows local jurisdictions to enact even stricter regulations regarding kratom sales, though they cannot set a purchasing age lower than 21. The primary aim of this bill appears to be protecting public health by controlling the distribution and marketing of kratom products.

Justice

https://www.senate.mo.gov/26info/BTS_Web/Bill.aspx?SessionType=R&BillID=521